Generic versus brand-name drugs used in cardiovascular diseases

Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes

(2014) Joshua J. Gagne et al.   ANNALS OF INTERNAL MEDICINE

Point-of-care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic and Branded Clopidogrel Bisulfate

(2014) Kyoung-Woo Seo et al.   CLINICAL THERAPEUTICS

Are generic and brand-name statins clinically equivalent? Evidence from a real data-base

(2014) Giovanni Corrao et al.   European Journal of Internal Medicine

High-Cost Generic Drugs — Implications for Patients and Policymakers

(2014) Jonathan D. Alpern et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non-publication and delayed publication of randomized trials on vaccines: survey

(2014) L. Manzoli et al.   BMJ-British Medical Journal

Comparison of Antiplatelet Efficacy and Tolerability of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients After Percutaneous Coronary Intervention: A Prospective, Multicenter, Randomized, Open-Label, Phase IV, Noninferiority Trial

(2013) Jun-Bean Park et al.   CLINICAL THERAPEUTICS

Efficacy and Safety of Two Ramipril and Hydrochlorothiazide Fixed-Dose Combination Formulations in Adults With Stage 1 or Stage 2 Arterial Hypertension Evaluated by Using ABPM

(2013) Wille Oigman et al.   CLINICAL THERAPEUTICS

Pharmacokinetic comparison and bioequivalence evaluation of losartan/ hydrochlorothiazide tablet between Asian Indian and Japanese volunteers

(2013) Sudershan Kumar et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Measuring the Global Burden of Disease

(2013) Christopher J.L. Murray et al.   NEW ENGLAND JOURNAL OF MEDICINE

A randomized comparison of platelet reactivity in patients after treatment with various commercial clopidogrel preparations: The CLO-CLO trial

(2012) Markus Oberhänsli et al.   Archives of Cardiovascular Diseases

Assessment of the Efficacy and Tolerability of 2 Formulations of Atorvastatin in Korean Adults With Hypercholesterolemia: A Multicenter, Prospective, Open-Label, Randomized Trial

(2012) Sang-Hyun Kim et al.   CLINICAL THERAPEUTICS

Branded Versus Generic Clopidogrel in Cardiovascular Diseases

(2012) Daniel Caldeira et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Efficacy and Safety of Innovator versus Generic Drugs in Patients with Epilepsy: A Systematic Review

(2012) Ripple Talati et al.   PHARMACOTHERAPY

The Effect of an Apparent Change to a Branded or Generic Medication on Drug Effectiveness and Side Effects

(2012) Kate Faasse et al.   PSYCHOSOMATIC MEDICINE

Meta-Analysis of Selective Serotonin Reuptake Inhibitors in Patients With Depression and Coronary Heart Disease

(2011) Carmine Pizzi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Antiplatelet Efficacy of Long-Term Treatment With Clopidogrel Besylate in Patients With a History of Acute Coronary Syndrome

(2011) Maria E. Tsoumani et al.   ANGIOLOGY

Physician Perceptions About Generic Drugs

(2011) William H Shrank et al.   ANNALS OF PHARMACOTHERAPY

Study on the bioequivalence of two formulations of eplerenone in healthy volunteers under fasting conditions: data from a single-center, randomized, single-dose, open-label, 2-way crossover bioequivalence study

(2011) Susana Almeida et al.   ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH

Effects of lifestyle intervention in persons at risk for type 2 diabetes mellitus - results from a randomised, controlled trial

(2011) Vegard Nilsen et al.   BMC PUBLIC HEALTH

Comparison of Antiplatelet Effect and Tolerability of Clopidogrel Resinate With Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD-Equivalent Risks: A Phase IV, Prospective, Double-Dummy, Parallel-Group, 4-Week Noninferiority Trial

(2011) Jung-Won Suh et al.   CLINICAL THERAPEUTICS

Effect of clopidogrel besylate on platelet reactivity in patients with acute coronary syndromes. Comparison with clopidogrel hydrogen sulfate

(2011) Maria E Tsoumani et al.   EXPERT OPINION ON PHARMACOTHERAPY

The Use Of Generic Drugs In Prevention Of Chronic Disease Is Far More Cost-Effective Than Thought, And May Save Money

(2011) William H. Shrank et al.   HEALTH AFFAIRS

Generic Atorvastatin and Health Care Costs

(2011) Cynthia A. Jackevicius et al.   NEW ENGLAND JOURNAL OF MEDICINE

Brand Name versus Generic Warfarin: A Systematic Review of the Literature

(2011) Francesco Dentali et al.   PHARMACOTHERAPY

Clinical Bioequivalence of a Dose of Clopidogrel Leti Cravid Tablets 75 mg Versus Clopidogrel Sanofi Plavix Tablets 75 mg Administered on a Daily Dose for 7 Days on Healthy Volunteers: A Clinical Trial

(2010) Aixa Müller et al.   AMERICAN JOURNAL OF THERAPEUTICS

Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: A multicenter, prospective, randomized, double-blind, double-dummy clinical trial

(2010) Sang-Hyun Kim et al.   CLINICAL THERAPEUTICS

Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males

(2010) Yan-Mei Liu et al.   CLINICAL THERAPEUTICS

Bioequivalence of two tablet formulations of clopidogrel in healthy argentinian volunteers: A single-dose, randomized-sequence, open-label crossover study

(2010) Guillermo Di Girolamo et al.   CLINICAL THERAPEUTICS

Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: A single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers

(2010) Muzaffar Iqbal et al.   CLINICAL THERAPEUTICS

Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers

(2010) Jing-Ying Jia et al.   CLINICAL THERAPEUTICS

The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study

(2010) Kun-Yan Li et al.   CLINICAL THERAPEUTICS

Comparison of effects of two different formulations of clopidogrel bisulfate tablets on platelet aggregation and bleeding time in healthy Korean volunteers: A single-dose, randomized, open-label, 1-week, two-period, phase IV crossover study

(2010) Chi Young Shim et al.   CLINICAL THERAPEUTICS

Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs

(2010) Aaron S. Kesselheim et al.   DRUGS

Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions

(2009) Ana Cristina Franco Spínola et al.   CLINICAL THERAPEUTICS

Bioequivalence of generic and branded subcutaneous enoxaparin: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjects

(2009) Limin Feng et al.   CLINICAL THERAPEUTICS

Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: An 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial

(2009) Sang-Hyun Kim et al.   CLINICAL THERAPEUTICS

Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: A randomized, open-label, crossover study in healthy Korean male subjects

(2009) Sung-Doo Kim et al.   CLINICAL THERAPEUTICS

Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: An open-label, single-dose, randomized, two-way crossover study in healthy chinese male volunteers

(2009) Yun Liu et al.   CLINICAL THERAPEUTICS

Patients’ Perceptions Of Generic Medications

(2009) William H. Shrank et al.   HEALTH AFFAIRS

Efficacy and safety profiles of a new S(—)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial

(2008) Sung Ai Kim et al.   CLINICAL THERAPEUTICS

Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease

(2008) Aaron S. Kesselheim   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION